Penserra Capital Management’s Transmedics TMDX Stock Holding History

Penserra Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,010	Closed	-$199K	–	1186
2026 Q1	$199K	Sell	2,010 -4,273	-68%	-$557K	﹤0.01%	672
2025 Q4	$764K	Buy	+6,283	New	+$788K	0.01%	485
2025 Q3	–	Sell	-18,090	Closed	-$2.42M	–	1092
2025 Q2	$2.42M	Buy	+18,090	New	+$1.99M	0.03%	316
2024 Q3	–	Sell	-21,391	Closed	-$3.22M	–	1314
2024 Q2	$3.22M	Buy	+21,391	New	+$2.57M	0.04%	295
2023 Q3	–	Sell	-38,846	Closed	-$3.26M	–	1373
2023 Q2	$3.26M	Buy	+38,846	New	+$2.97M	0.06%	223

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Penserra Capital Management's TMDX Position: Q2 2026 in Review

Penserra Capital Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,010 shares — an estimated $199K sold.

Penserra Capital Management first reported a position in TMDX in Q2 2023 and held it in 5 quarters. The position peaked at $3.26M in Q2 2023. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Penserra Capital Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
Penserra Capital Management sold 2,010 Transmedics shares in Q2 2026, an estimated $199K.
Penserra Capital Management first reported a position in Transmedics in Q2 2023 and held it in 5 quarters.
Penserra Capital Management's Transmedics position peaked at $3.26M in Q2 2023.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.